Back

Neural and subjective effects of inhaled DMT in natural settings

Pallavicini, C.; Cavanna, F.; Zamberlan, F.; de la Fuente, L. A.; Arias, M.; Romero, M. C.; Carhart-Harris, R.; Timmermann, C.; Tagliazucchi, E.

2020-08-20 neuroscience
10.1101/2020.08.19.258145 bioRxiv
Show abstract

BackgroundN,N-Dimethyltryptamine (DMT) is a short acting psychedelic tryptamine found naturally in many plants and animals. Few studies to date addressed the neural and psychological effects of DMT alone, either administered intravenously or inhaled in freebase form, and none conducted in natural settings. AimsOur primary aim was to study the acute effects of inhaled DMT in natural settings, focusing on questions tuned to the advantages of conducting field research, including the effects of contextual factors (i.e. "set" and "setting"), the possibility of studying a comparatively large number of subjects, and the relaxed mental state of participants consuming DMT in familiar and comfortable settings. MethodsWe combined state-of-the-art wireless electroencephalography (EEG) with psychometric questionnaires to study the neural and subjective effects of naturalistic DMT use in 35 healthy and experienced participants. ResultsWe observed that DMT significantly decreased the power of alpha (8-12 Hz) oscillations throughout all scalp locations, while simultaneously increasing power of delta (1-4 Hz) and gamma (30-40 Hz) oscillations. Gamma power increases correlated with subjective reports indicative of mystical-type experiences. DMT also increased/decreased global synchrony and metastability in the gamma/alpha band, and resulted in widespread increases in signal complexity. ConclusionsOur results are consistent with previous studies of psychedelic action in the human brain, while at the same time suggesting potential EEG markers of mystical-type experiences in natural settings, thus highlighting the importance of investigating these compounds in the contexts where they are naturally consumed.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 6%
10.3%
2
Journal of Psychopharmacology
14 papers in training set
Top 0.1%
10.3%
3
PLOS ONE
4510 papers in training set
Top 21%
8.5%
4
Psychopharmacology
59 papers in training set
Top 0.1%
8.3%
5
Physiology & Behavior
30 papers in training set
Top 0.1%
4.9%
6
Frontiers in Psychiatry
83 papers in training set
Top 1%
3.6%
7
Neuropsychopharmacology
134 papers in training set
Top 0.8%
3.6%
8
Neuropharmacology
60 papers in training set
Top 0.3%
3.1%
50% of probability mass above
9
Behavioural Brain Research
70 papers in training set
Top 0.3%
2.8%
10
Frontiers in Nutrition
23 papers in training set
Top 0.5%
2.4%
11
eneuro
389 papers in training set
Top 5%
1.7%
12
Translational Psychiatry
219 papers in training set
Top 3%
1.7%
13
Nature Human Behaviour
85 papers in training set
Top 3%
1.2%
14
European Neuropsychopharmacology
15 papers in training set
Top 0.4%
1.2%
15
Addiction Neuroscience
17 papers in training set
Top 0.4%
1.0%
16
NeuroToxicology
11 papers in training set
Top 0.2%
1.0%
17
Neurotherapeutics
11 papers in training set
Top 0.3%
1.0%
18
Brain Research
35 papers in training set
Top 1%
0.9%
19
NeuroImage
813 papers in training set
Top 5%
0.9%
20
Pharmaceuticals
33 papers in training set
Top 1%
0.9%
21
Neuroscience of Consciousness
12 papers in training set
Top 0.3%
0.9%
22
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.3%
0.8%
23
Frontiers in Public Health
140 papers in training set
Top 8%
0.8%
24
Pharmaceutics
21 papers in training set
Top 0.4%
0.8%
25
Frontiers in Neuroscience
223 papers in training set
Top 7%
0.8%
26
International Journal of Drug Policy
11 papers in training set
Top 0.3%
0.8%
27
Neuroscience Letters
28 papers in training set
Top 1%
0.7%
28
Nutrients
64 papers in training set
Top 2%
0.7%
29
Frontiers in Psychology
49 papers in training set
Top 2%
0.5%
30
Imaging Neuroscience
242 papers in training set
Top 4%
0.5%